Middle East & Africa Gastric Cancer Diagnostics Market Size & Outlook
MEA gastric cancer diagnostics market highlights
- The MEA gastric cancer diagnostics market generated a revenue of USD 40.8 million in 2024.
- The market is expected to grow at a CAGR of 7.2% from 2025 to 2033.
- In terms of segment, reagents and consumables was the largest revenue generating product in 2024.
- Reagents and Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2024 | USD 40.8 million |
| Market revenue in 2033 | USD 75.6 million |
| Growth rate | 7.2% (CAGR from 2025 to 2033) |
| Largest segment | Reagents and consumables |
| Fastest growing segment | Reagents and Consumables |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents and Consumables |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.5% of the global gastric cancer diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 298.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gastric Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Shijiazhuang Hipro Biotechnology Co. | View profile | 251-500 | Shijiazhuang, Hebei, China, Asia | https://www.hipro.us |
| Endofotonics | View profile | 11-50 | Singapore, Central Region, Singapore, Asia | http://www.endofotonics.com/ |
| Mirxes | View profile | 101-250 | Singapore, Central Region, Singapore, Asia | http://www.mirxes.com |
| Abbott | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Bio-Rad Laboratories, Inc. | View profile | - | - | - |
| Fulgent Genetics Inc | View profile | 1012 | 4399 Santa Anita Avenue, El Monte, CA, United States, 91731 | https://www.fulgentgenetics.com |
| Exact Sciences Corp | View profile | 6600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | https://www.exactsciences.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
Middle East & Africa gastric cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gastric cancer diagnostics market will help companies and investors design strategic landscapes.
Reagents and consumables was the largest segment with a revenue share of 106.13% in 2024. Horizon Databook has segmented the Middle East & Africa gastric cancer diagnostics market based on reagents and consumables covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Middle East & Africa gastric cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa gastric cancer diagnostics market databook
-
Our clientele includes a mix of gastric cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa gastric cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa gastric cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
